wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28553066-5CA18EDE-8257-4B9D-8CF4-4338E560DFA3
Q28553066-5CA18EDE-8257-4B9D-8CF4-4338E560DFA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28553066-5CA18EDE-8257-4B9D-8CF4-4338E560DFA3
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice
P2860
Q28553066-5CA18EDE-8257-4B9D-8CF4-4338E560DFA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28553066-5CA18EDE-8257-4B9D-8CF4-4338E560DFA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ec122cf58ba94a6a5765a26bfeba4ac4e6cb1c0
P2860
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.